References
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.
Einhorn D, Reaven GM, Cobin RH. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2002;9:236–52.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.
NECP: ATP III. Executive summary of the National Cholesterol Education Program (NECP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486–97.
Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med. 2003;4(6):S11–8.
Mittra S, Bansal VS, Bhatnagar PK. From a glucocentric to a lipocentric approach towards metabolic syndrome. Drug Discov Today. 2008;13:211–8.
de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54:945–55.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.
Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–35.
Grundy SM. Inflammation, metabolic syndrome, and diet responsiveness. Circulation. 2003;108:126–8.
Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm. 2010; Article ID 289645. doi:10.1155/2010/289645.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, P. Inflammation and the Metabolic Syndrome. Ind J Clin Biochem 26, 317–318 (2011). https://doi.org/10.1007/s12291-011-0175-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-011-0175-6